Fig. 4From: The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient managementExpression mean for each marker in BRAF WT and V600E malignant samples. KIT - TC1 (a) and miR-222 - miR-146b (b) expression in BRAF wild-type versus V600E malignant lesionsBack to article page